Title: Decline in reported GC morbidity in NYC
1Decline in reported GC morbidity in NYC
- Preeti Pathela
- ppathela_at_health.nyc.gov
2Gonorrhea
Where do we stand?
NYC
NYC
NYC
US
US
Cases per 100,000 pop.
US
3Gonorrhea Rates United States, 1970-2004 and
the Healthy People 2010 target
-74
-12
4Gonorrhea Rates by Sex United States, 1981-2004
and the Healthy People 2010 target
5Gonorrhea Rates by Sex New York City, 1995-2005
Data based on cases reported to the NYC DOHMH
6Gonorrhea Rates by Provider Type United States,
1984-2004
7Case rate (per 100,000 population) of Neisseria
gonorrhea reported to the New York City DOHMH,
with percent reported from Bureau of STD clinics,
2000-2005, by sex
Data based on cases reported to the NYC DOHMH
8Provider types in NYC BSTDC Surveillance Database
HIV Counseling Testing STD Clinic Drug
Treatment Family Planning Prenatal Other
Clinic Private Physician Hospital Correctional
Facility Laboratory Other Unknown
9N6720
N6330
N5507
N5286
10NYC DOHMH Reported female gonorrhea cases, by
provider type 2002 - 2005
N6691
N6646
N5048
N5544
11Gonorrhea reported to the NYC DOHMH. Case rates
(per 100,000 population) by age and sex, full
year 2004
Males
Females
N5286
N5544
10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50
-54 55-59 60-64 65
Age (years)
Case rate /100,000 population
Excludes persons for whom age or sex
information is missing.
12Male GC positivity by age BSTDC clinics,
2003-2005
13Female GC positivity by age BSTDC clinics,
2003-2005
14What is leading to the apparent decline in GC
cases?
- A true decline in GC
- Changes in screening practices
-
- Use of diagnostic tests with different
sensitivities - Changes in reporting practices
15If decreases are true decreases
- How would this impact targeting of GC screening?
- Could this impact manufacturers of tests
- (provision of Ct-only tests) for low GC
prevalence areas?
16